Cardiovascular Systems, Inc.
(CSII)
Monteverde & Associates Announces the Investigation of Cardiovascular Systems, Inc.
Sumo Logic, Inc.
(SUMO)
Monteverde & Associates Announces the Investigation of Sumo Logic, Inc.
Oak Street Health, Inc.
(OSH)
Monteverde & Associates Announces the Investigation of Oak Street Health, Inc.
Argo Group International Holdings, Ltd.
(ARGO)
Monteverde & Associates Announces the Investigation of Argo Group International Holdings, Ltd.
AlerisLife Inc.
(ALR)
Monteverde & Associates Announces the Investigation of AlerisLife Inc.
Chembio Diagnostics, Inc.
(CEMI)
Monteverde & Associates Announces the Investigation of Chembio Diagnostics, Inc.
Atlas Technical Consultants, Inc.
(ATCX)
Monteverde & Associates Announces the Investigation of Atlas Technical Consultants, Inc.
Concert Pharmaceuticals, Inc.
(CNCE)
Monteverde & Associates Announces the Investigation of Concert Pharmaceuticals, Inc.
Leap Therapeutics, Inc.
(LPTX)
Monteverde & Associates Announces the Investigation of Leap Therapeutics, Inc.
Angion Biomedica Corp.
(ANGN)
Monteverde & Associates Announces the Investigation of Angion Biomedica Corp.
Golden Matrix Group, Inc.
(GMGI)
Monteverde & Associates Announces the Investigation of Golden Matrix Group, Inc.
Duck Creek Technologies, Inc.
(DCT)
Monteverde & Associates Announces the Investigation of Duck Creek Technologies, Inc.
Paya Holdings Inc.
(PAYA)
Monteverde & Associates Announces the Investigation of Paya Holdings Inc.
Albireo Pharma, Inc.
(ALBO)
Monteverde & Associates Announces the Investigation of Albireo Pharma, Inc.
